Invitae Wants Myriad's Gene-Testing Patent Suit Tossed

Law360, New York (December 10, 2013, 10:28 PM ET) -- Genetic testing company Invitae Corp. asked a Utah federal court Monday to throw out Myriad Genetics Inc.’s suit alleging Invitae infringed on its patents relating to genetic screening for breast cancer, saying the court lacks jurisdiction because Invitae has no contacts in Utah.

Invitae’s motion asserts that although the patent infringement suit by Utah-based Myriad would fail on its merits, the court should dismiss it immediately because it lacks jurisdiction over San Francisco-based Invitae. Invitae argues it cannot be sued in Utah because it does not...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers

Required